Correlation Between Enliven Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Enliven Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Structure Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Structure Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and Structure is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Structure Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.82 times less risky than Structure Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Structure Therapeutics American is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 3,744 in Structure Therapeutics American on August 28, 2024 and sell it today you would lose (343.00) from holding Structure Therapeutics American or give up 9.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Structure Therapeutics America
Performance |
| Timeline |
| Enliven Therapeutics |
| Structure Therapeutics |
Enliven Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |